Recent Quotes (30 days)

You have no recent quotes
chg | %

Market summary

9:32am BST

World markets

Shanghai 2,938.32 -7.27 (-0.25%)
S&P 500 2,075.81 -19.34 (-0.92%)
Nikkei 225 16,666.05 -624.44 (-3.61%)
Hang Seng Index 21,067.05 -320.98 (-1.50%)
TSEC 8,377.90 -95.97 (-1.13%)
EURO STOXX 50 3,080.70 -44.73 (-1.43%)
CAC 40 4,492.33 -65.03 (-1.43%)
S&P TSX 13,886.43 -1.23 (-0.01%)
S&P/ASX 200 5,252.20 +26.80 (0.51%)
BSE Sensex 25,465.58 -137.52 (-0.54%)
TA25 1,438.66 -25.23 (-1.72%)
SMI 8,002.81 -96.61 (-1.19%)
ATX 2,331.29 -12.68 (-0.54%)
IBOVESPA 54,311.96 -165.82 (-0.30%)
SET 1,399.27 -0.64 (-0.05%)
BIST100 85,253.51 -224.32 (-0.26%)
IBEX 9,146.90 -122.10 (-1.32%)
WIG 47,467.95 -175.75 (-0.37%)
TASI 6,805.84 -14.46 (-0.21%)
MERVAL 13,127.12 -67.65 (-0.51%)
IPC 45,528.93 -412.59 (-0.90%)
IDX Composite 4,827.32 -21.07 (-0.43%)

Currencies

GBP/USD 1.4611 0.0000 (0.00%)
GBP/EUR 1.2838 -0.0026 (-0.20%)
GBP/JPY 156.3691 -1.5759 (-1.00%)
GBP/HKD 11.3354 +0.0005 (0.00%)
GBP/CNY 9.4738 +0.0135 (0.14%)
GBP/AUD 1.9155 +0.0011 (0.06%)
RBS reveals �1bn loss and Swiss inquiry into Coutts subsidiary
People walk past the Coutts bank in Zurich, now under investigation by Swiss authorities. Photograph: Arnd Wiegmann/Reuters. Jill Treanor.
RBS losses double to nearly �1bn  
RBS reports �968m loss after government payment  
Market Chart
6,277.84 -44.56 (-0.70%)
16,969.31 -97.14 (-0.57%)
3,443.74 -22.66 (-0.65%)
3,757.26 -27.98 (-0.74%)

Top stories

Philip Green doesn't do empathy. Green's retail is red in tooth and claw. Now his pugilistic, foul-mouthed response to criticism has returned to bite him where it hurts.
Consumer confidence fell to a 15-month low in April as optimism about the UK economy faded ahead of the EU referendum. GfK's latest confidence barometer dipped into negative territory for the first time since December 2014 as cautious households said ...
Restaurant Group Plc (RTN.L) on Friday warned on full-year profit outlook as it does not expect any improvement in trading conditions in the short term.
Investors intensified the fight against high pay for poor performance in a bruising day of shareholder activism at some of Britain's biggest companies.
LONDON AstraZeneca (AZN.L) is increasing its focus on cancer treatments in a drive to streamline operations after underlying earnings, hit by drug patent expiries, fell 12 percent in the first quarter, broadly in line with analyst expectations.

Trends

Popular searches on GoogleChange Mkt Cap
SBRY J Sainsbury plc -0.48% 5,590.40M
BOO Boohoo.Com PLC -2.99% 547.59M